ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$1.53B |
| 2 |
Tesla
TSLA
|
+$1.24B |
| 3 |
XYZ
Block Inc
XYZ
|
+$911M |
| 4 |
Zoom
ZM
|
+$754M |
| 5 |
Baidu
BIDU
|
+$748M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$509M |
| 2 |
CRISPR Therapeutics
CRSP
|
+$321M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$314M |
| 4 |
Pacific Biosciences
PACB
|
+$252M |
| 5 |
PayPal
PYPL
|
+$229M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.99% |
| 2 | Technology | 24.49% |
| 3 | Communication Services | 14.26% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Financials | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fate Therapeutics
FATE
$326M
| $540M | 1.07% |
6,554,546
+3,652,846
| +126% | +$350M |
|
|
TWTR
27
DELISTED
Twitter, Inc.
TWTR
| $496M | 0.99% |
+7,793,240
| New | +$476M |
|
|
TWOU
28
DELISTED
2U Inc
TWOU
| $453M | 0.9% |
394,569
-47,484
| -11% | -$60.2M |
|
29
Protolabs
PRLB
$2.13B
| $445M | 0.88% |
3,654,854
-465,068
| -11% | -$77.3M |
|
30
Palantir
PLTR
$413B
| $434M | 0.86% |
18,632,471
+17,315,349
| +1,315% | +$475M |
|
31
Iridium Communications
IRDM
$5.29B
| $427M | 0.85% |
10,355,147
+3,384,917
| +49% | +$148M |
|
32
Veracyte
VCYT
$3.8B
| $409M | 0.81% |
7,617,287
-1,410,540
| -16% | -$81.2M |
|
|
33
PayPal
PYPL
$50.5B
| $408M | 0.81% |
1,679,629
-905,060
| -35% | -$229M |
|
34
PagerDuty
PD
$902M
| $402M | 0.8% |
9,982,602
-1,565,231
| -14% | -$71.5M |
|
35
JD.com
JD
$44.5B
| $392M | 0.78% |
4,651,745
+3,013,962
| +184% | +$276M |
|
36
Beam Therapeutics
BEAM
$2.84B
| $383M | 0.76% |
4,779,104
+3,647,481
| +322% | +$347M |
|
37
Synopsys
SNPS
$79.7B
| $381M | 0.76% |
1,537,753
+516,571
| +51% | +$131M |
|
38
Vertex Pharmaceuticals
VRTX
$126B
| $369M | 0.73% |
1,719,046
+902,852
| +111% | +$198M |
|
39
Editas Medicine
EDIT
$442M
| $368M | 0.73% |
8,751,923
-1,373,641
| -14% | -$78.3M |
|
40
LendingTree
TREE
$451M
| $367M | 0.73% |
1,723,091
-287,164
| -14% | -$81.7M |
|
41
Teradyne
TER
$59.3B
| $350M | 0.7% |
2,877,103
+2,639,056
| +1,109% | +$332M |
|
42
Takeda Pharmaceutical
TAK
$55.7B
| $342M | 0.68% |
18,717,144
+10,098,979
| +117% | +$182M |
|
43
CareDx
CDNA
$2.42B
| $304M | 0.6% |
4,460,824
+398,502
| +10% | +$30.9M |
|
44
PACCAR
PCAR
$70.1B
| $293M | 0.58% |
+4,736,478
| New | +$296M |
|
|
SI
45
DELISTED
Silvergate Capital Corporation
SI
| $276M | 0.55% |
1,939,369
+1,308,580
| +207% | +$155M |
|
46
Stratasys
SSYS
$774M
| $270M | 0.54% |
10,420,260
-1,667,401
| -14% | -$57.5M |
|
47
DraftKings
DKNG
$11.9B
| $268M | 0.53% |
+4,375,424
| New | +$263M |
|
|
MTLS
48
Materialise
MTLS
$396M
| $268M | 0.53% |
7,441,821
-1,122,260
| -13% | -$62.5M |
|
|
CELL
49
DELISTED
PhenomeX Inc. Common Stock
CELL
| $257M | 0.51% |
5,115,992
+3,651,475
| +249% | +$249M |
|
50
Opendoor
OPEN
$3.38B
| $247M | 0.49% |
12,029,362
+7,894,762
| +191% | +$208M |
|
Similar funds
ARK Investment Management's Q1 2021 Portfolio in Review
As of Q1 2021, ARK Investment Management held 298 positions worth $50.3B, up 34% from $37.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
ARK Investment Management deployed $15.9B of net new capital in Q1 2021, opening 54 new positions and adding to 184 existing holdings. Its largest new stake was Twitter, Inc.: 7,793,240 shares worth $496M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was TSMC, an estimated $509M trimmed.
- ARK Investment Management's largest Q1 2021 buy was Twitter, Inc.: 7,793,240 shares worth $496M.
- ARK Investment Management added most to Teladoc Health in Q1 2021, an estimated $1.53B increase.
- ARK Investment Management's biggest Q1 2021 reduction was TSMC, cutting an estimated $509M.
- ARK Investment Management fully exited Salesforce in Q1 2021, selling an estimated $99.4M.
- ARK Investment Management's ten largest holdings make up 35% of its $50.3B portfolio in Q1 2021.
- ARK Investment Management opened 54 new positions and closed 8 in Q1 2021.
- ARK Investment Management's portfolio value rose 34% quarter-over-quarter to $50.3B.
Based on ARK Investment Management's 13F filing for Q1 2021, filed 13 May 2021.